Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastomaMark C. de Gooijer, Olaf van Tellingen, J.H. Beijnen et al.|Cellular Oncology|2026Cited by 0